SM
SG3 Management Portfolio holdings
AUM
$6.45K
This Quarter Return
+0.56%
1 Year Return
-62.95%
3 Year Return
-60.35%
5 Year Return
-56.94%
10 Year Return
–
AUM
$282M
AUM Growth
+$282M
(+20%)
Cap. Flow
+$44.5M
Cap. Flow
% of AUM
15.78%
Top 10 Holdings %
Top 10 Hldgs %
41.57%
Holding
793
New
124
Increased
53
Reduced
53
Closed
143
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$40M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$10.3M |
| 3 |
Bausch Health
BHC
|
$7.27M |
| 4 |
Albemarle
ALB
|
$6.79M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$6.66M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$24.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$10M |
| 3 |
Amgen
AMGN
|
$7.8M |
| 4 |
Pinduoduo
PDD
|
$6.55M |
| 5 |
Cracker Barrel
CBRL
|
$5.94M |
Sector Composition
| 1 | Healthcare | 38.32% |
| 2 | Communication Services | 18.14% |
| 3 | Technology | 10.64% |
| 4 | Consumer Discretionary | 8.64% |
| 5 | Financials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class C
GOOG
$2.58T
| $40M | 1.21% | +15,000 | New | +$40M |
|
2
Moderna
MRNA
$9.37B
| $20.2M | 0.61% | 52,500 +13,600 | +35% | +$5.23M |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $10.3M | 0.31% | +60,000 | New | +$10.3M |
|
|
4
Albemarle
ALB
$9.99B
| $8.43M | 0.26% | 38,500 +31,000 | +413% | +$6.79M |
|
|
5
Bausch Health
BHC
$2.74B
| $7.8M | 0.24% | 280,000 +261,000 | +1,374% | +$7.27M |
|
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $7.6M | 0.23% | 40,250 +35,250 | +705% | +$6.66M |
|
7
JD.com
JD
$44.1B
| $6.14M | 0.19% | 85,000 +83,500 | +5,567% | +$6.03M |
|
8
AstraZeneca
AZN
$248B
| $6.13M | 0.19% | 102,100 +74,600 | +271% | +$4.48M |
|
9
AMN Healthcare
AMN
$796M
| $5.51M | 0.17% | +48,000 | New | +$5.51M |
|
|
NBIS
10
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $5.1M | 0.15% | 64,000 +10,000 | +19% | +$797K |
|
|
INOV
11
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $4.23M | 0.13% | +105,000 | New | +$4.23M |
|
12
Vir Biotechnology
VIR
$686M
| $3.55M | 0.11% | +81,500 | New | +$3.55M |
|
13
Airbnb
ABNB
$79.9B
| $3.52M | 0.11% | +21,000 | New | +$3.52M |
|
14
Simon Property Group
SPG
$59B
| $3.51M | 0.11% | 27,000 -3,000 | -10% | -$390K |
|
15
Editas Medicine
EDIT
$231M
| $3.39M | 0.1% | +82,500 | New | +$3.39M |
|
16
Apellis Pharmaceuticals
APLS
$3.48B
| $3.3M | 0.1% | 100,000 +90,000 | +900% | +$2.97M |
|
17
Biogen
BIIB
$19.4B
| $3.25M | 0.1% | +11,500 | New | +$3.25M |
|
18
Target
TGT
$43.6B
| $3.2M | 0.1% | +14,000 | New | +$3.2M |
|
19
Veeva Systems
VEEV
$44B
| $3.17M | 0.1% | +11,000 | New | +$3.17M |
|
20
FIVE9
FIVN
$2.08B
| $2.96M | 0.09% | +18,500 | New | +$2.96M |
|
21
Welltower
WELL
$113B
| $2.93M | 0.09% | +35,600 | New | +$2.93M |
|
|
SGI
22
Somnigroup International Inc.
SGI
$17.6B
| $2.72M | 0.08% | 58,500 -21,500 | -27% | -$998K |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.48M | 0.08% | +14,000 | New | +$2.48M |
|
24
PAR Technology
PAR
$2.08B
| $2.46M | 0.07% | +40,000 | New | +$2.46M |
|
25
Comcast
CMCSA
$125B
| $2.24M | 0.07% | 40,000 +7,500 | +23% | +$419K |
|